TALLC at the Ophthalmology Innovation Summit

TALLC to introduce TA-A001, our proprietary CB2R agonist, and the enabling effects of SmartCelle ocular delivery technology at the Ophthalmology Innovation Summit: Drug Delivery Showcase.